Iridex (IRIX) Capital Expenditures Growth (3y) (2014 - 2026)
Iridex (IRIX) Capital Expenditures Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 8.08% |
| 10 | Iridex | 19.91 Mn | 15.31 Mn | 4.74 Mn | 32.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 32.93% |
| Jan 3, 2026 | 8.49% |
| Sep 27, 2025 | -38.90% |
| Jun 28, 2025 | -52.33% |
| Mar 29, 2025 | -24.93% |
| Dec 28, 2024 | -58.51% |
| Mar 30, 2024 | -65.49% |
| Sep 30, 2023 | 117.22% |
| Jul 1, 2023 | 13.30% |
| Apr 1, 2023 | -14.17% |
| Dec 31, 2022 | 202.45% |
| Oct 1, 2022 | 59.68% |
| Jul 2, 2022 | 39.71% |
| Apr 2, 2022 | -27.06% |
| Jan 1, 2022 | 37.00% |
| Apr 3, 2021 | -35.65% |
| Sep 26, 2020 | -57.74% |
| Jun 27, 2020 | -51.26% |
| Mar 28, 2020 | -41.58% |
| Dec 28, 2019 | -77.69% |